All Stories

  1. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

    Article • Drug Design Development and Therapy, April 2018, Dove Medical Press

    Martin Hoenigl

  2. Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels

    Article • Antimicrobial Agents and Chemotherapy, June 2016, ASM Journals

    Martin Hoenigl

  3. Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?

    Article • Journal of Clinical Microbiology, December 2015, ASM Journals

    Martin Hoenigl

  4. Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies

    Article • Journal of Clinical Microbiology, December 2015, ASM Journals

    Martin Hoenigl

  5. Clinical Evaluation of Multiple Inflammation Biomarkers for Diagnosis and Prognosis for Patients with Systemic Inflammatory Response Syndrome

    Article • Journal of Clinical Microbiology, September 2014, ASM Journals

    Martin Hoenigl

  6. Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

    Article • Journal of Clinical Microbiology, March 2014, ASM Journals

    Martin Hoenigl

  7. First Report of Nocardia asiatica Olecranon Bursitis in an Immunocompetent Traveler Returning to Austria

    Article • Journal of Clinical Microbiology, May 2013, ASM Journals

    Martin Hoenigl

  8. Voriconazole Plasma Concentrations

    Article • Antimicrobial Agents and Chemotherapy, April 2013, ASM Journals

    Martin Hoenigl